Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Grazoprevir plus Elbasvir in Japanese Patients with HCV Genotype 1b and CKD Stage 3
NCT03144635Phase 4Completed
- Sponsor
- Kyushu University
- Start
- Apr 2017
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of grazoprevir, elbasvir in hepatitis C (HCV), sponsored by Kyushu University. Started Apr 2017; status: completed.
02
Drugs
grazoprevirelbasvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT03144635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03144635.